Trials / Conditions / Liposarcoma, Dedifferentiated

Liposarcoma, Dedifferentiated

6 registered clinical trials studyying Liposarcoma, Dedifferentiated — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dediffe NCT06058793	Boehringer Ingelheim	Phase 3
Terminated	Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas NCT05580588	Shanghai Pharma Biotherapeutics USA Inc.	Phase 2
Completed	Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Call NCT05218499	Boehringer Ingelheim	Phase 2 / Phase 3
Completed	Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease Afte NCT04794127	Mario Negri Institute for Pharmacological Research	Phase 2
Recruiting	Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients NCT07432932	Royal Marsden NHS Foundation Trust	—
Unknown	Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas NCT03989596	Maria Sklodowska-Curie National Research Institute of Oncology	Phase 2